Skip to main content
Equibles
COAG logo

COAG · Hemab Therapeutics Holdings, Inc. · Executive Compensation

Track COAG — free

Use COAG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research COAG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$31.11 +0.05 (+0.16%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$1.52B
Shares
46.71M
Volume · Oct 2 354.15K Avg daily vol (3M) 454.32K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Keli Walbert Appointed 2026-09-24
Laura Tadvalkar, Ph.D. Resigned 2026-05-11
Key facts CIK 2114044 CUSIP 423494103 13F (30d) 2 filings 2 filers Visit website Investor relations